Movianto signs deal with Bayer for Czech distribution
Movianto Ceska republika, an operation of Movianto Group, a specialist pharmaceutical and health care logistics provider, has signed an exclusive contract with Bayer sro.
Movianto will provide warehousing and distribution services for Bayer's Consumer Care product range for the whole Czech republic health care market. The product range comprises analgesics, cough and cold remedies, gastrointestinal and dermatological products and multivitamin and dietary supplements.
Movianto's managing director, Roman Harviscak, commented: "our warehousing and logistics services offers Bayer Consumer Care a real opportunity to enhance their supply chain and to increase the flexibility in delivering the products to their clients."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze